Assertio Therapeutics
ASRT
#9509
Rank
NZ$0.13 B
Marketcap
NZ$1.36
Share price
0.99%
Change (1 day)
-14.15%
Change (1 year)

Earnings for Assertio Therapeutics (ASRT)

Earnings in 2025 (TTM): -NZ$45.11 Million

According to Assertio Therapeutics 's latest financial reports the company's current earnings are NZ$0.13 Billion. In 2024 the company made an earning of -NZ$32.74 Million, an increase over its 2023 earnings that were of -NZ$0.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Assertio Therapeutics from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$45.11 Million37.79%
2024 -NZ$32.74 Million-92.46%
2023 -NZ$0.44 Billion-744.93%
2022 NZ$67.33 M304.52%
2021 NZ$16.64 M-132.53%
2020 -NZ$51.17 Million-81.97%
2019 -NZ$0.29 Billion-253.57%
2018 NZ$0.18 B-451.81%
2017 -NZ$52.53 Million-258.05%
2016 NZ$33.23 M-138.59%
2015 -NZ$86.13 Million-121.01%
2014 NZ$0.40 B2275.01%
2013 NZ$17.25 M-133.45%
2012 -NZ$51.6 Million-141.87%
2011 NZ$0.12 B1496.17%
2010 NZ$7.71 M-121.23%
2009 -NZ$36.36 Million22.98%
2008 -NZ$29.57 Million-135.96%
2007 NZ$82.2 M
2003 -NZ$50.84 Million
2000 -NZ$13.39 Million43.5%
1999 -NZ$9.33 Million58.6%
1998 -NZ$5.88 Million580%
1997 -NZ$0.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-NZ$31.4 Million-31.08%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-NZ$0.28 Billion 505.39%๐Ÿ‡บ๐Ÿ‡ธ USA